> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-positive.md).

# Triple-Positive

This section is for **triple-positive breast cancer** topics.

Triple-positive breast cancer means the cancer is:

* **ER-positive**
* **PR-positive**
* **HER2-positive**

That combination means it sits at the overlap of two major treatment logics:

* **endocrine / receptor-positive treatment questions**
* **HER2-targeted treatment questions**

That is why this subtype often needs its own home, even when some of the most useful material still overlaps with the ER-positive and HER2-positive sections.

### What this subtype usually raises

Triple-positive disease often brings a mixed set of questions, such as:

* how ER and HER2 signalling interact
* when endocrine resistance matters
* how HER2-targeted therapy changes the picture
* how subtype labels like luminal B may overlap with treatment thinking
* where support threads sit when a question is partly endocrine and partly HER2-driven

### Relevant support group threads and docs

#### Triple-positive-specific thread

* 💬 [Triple Positive Breast Cancer (TPBC)](https://www.facebook.com/groups/healingcancerstudysupport/permalink/1045020609746888/)

### Current overlap pages are worth checking

Until this section grows further, the most relevant overlap pages currently live in the **HER2-Positive** and **ER-Positive / HER2-Negative** sections.

#### More HER2-linked material

* [HER2-Positive](/myhealingcommunity-docs/breast-cancer/her2-positive.md)
* [Support Threads & Docs](/myhealingcommunity-docs/breast-cancer/her2-positive/support-threads-and-docs.md)
* [Should HER2+/ERα+ Patients Avoid Resveratrol or Polydatin?](/myhealingcommunity-docs/breast-cancer/her2-positive/should-her2+-era+-patients-avoid-resveratrol-or-polydatin.md)
* [Enhertu and Cancer Cell Senescence](/myhealingcommunity-docs/breast-cancer/her2-positive/enhertu-senescence-and-the-senolytic-second-strike.md)

#### More ER-linked material

* [ER-Positive / HER2-Negative](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative.md)
* [ER+/PR- Receptor Status](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/er+-pr-receptor-status.md)
* [Distinguishing Luminal A from Luminal B](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/distinguishing-luminal-a-from-luminal-b.md)
* [Support Threads & Docs](/myhealingcommunity-docs/breast-cancer/support-threads-and-docs.md)

### How this section will grow

This section will expand to include:

* triple-positive-treatment-specific resistance questions
* endocrine-plus-HER2 treatment overlap notes
* support-thread links pulled across from both ER-positive and HER2-positive sections
* subtype-specific practical questions on sequencing, side effects, and adjunctive support


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-positive.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.